Article Listing - SITS-MOST results confirm Actilyse's safety as a treatment for ischemic stroke

CELL GENESYS/MEDIMMUNE DEAL

11 May 1992

Cell GeneSys has struck a deal with MedImmune covering the licensing of the latter's antibody products targeted at treating patients...

SPAIN LACKS CONCRETE HEALTH POLICY

11 May 1992

The three main issues affecting health care in Spain last year were: the setting up of the Abril commission...

LILLY/BIOJECT DEAL

11 May 1992

Eli Lilly and Bioject have entered into a $4 million deal to develop and market new products using the latter's...

McNEIL - ANTHONY TEMPLE

11 May 1992

Anthony Temple has been appointed executive director, medical, in the McNeil Consumer Products Co division of Johnson & Johnson, following...

ICN GALENIKA FIRST QTR RESULTS

11 May 1992

ICN Galenika, based in the former Yugoslav capital Belgrade, recorded a turnover of $120 million for the first quarter of...

RHONE-POULENC RORER LOOKS EAST

11 May 1992

One of the major prospects for future business for Rhone-Poulenc Rorer GmbH based in Germany lies in eastern Europe, executive...

GENENTECH'S DNase EFFECTIVE IN CF

11 May 1992

Results of a US Phase II study have demonstrated that Genentech's DNase is an effective treatment for the chronic lung...

ZOFRAN APPROVED IN UK FOR PONV

11 May 1992

Glaxo has received marketing approval from the UK regulatory authorities for its 5-HT3 antagonist Zofran (ondansetron) as a treatment for...

CHANGES IN ISRAELI DRUG COSTS TO CONSUMERS

11 May 1992

Israel's Ministry of Health has announced further changes in the pricing of medicines supplied through private pharmacies to the public,...

HAI SLAMS "MISLEADING" DRUG PROMOTION

11 May 1992

End-April saw the launch in Geneva, Switzerland of independent consumer pressure group Health Action International's new publication, entitled Promoting Health...

Showing 94181-94190 of 95576 articles